Mederma® Introduces The First And Only Nighttime Scar Care Product

GREENSBORO, N.C., March 31, 2014 /PRNewswire/ -- The makers of Mederma®, the #1 doctor-¹ and pharmacist-² recommended brand for scars, announced today the introduction of Mederma® PM Intensive Overnight Scar Cream, a new one-of-a-kind scar cream formulated to work at night, when skin naturally regenerates faster. Mederma® PM is clinically shown to improve the overall appearance, size, color and texture of scars, making them softer, smoother and less noticeable. The cream is also formulated with Tripeptol™, a skin-nourishing complex with peptides, collagen, and antioxidants that complement the increased nighttime regeneration of the skin to promote healthy looking skin.

"In my practice, patients want to reduce the appearance of scars, but they also want to see results quickly. During sleep, the body works harder to reverse the skin damage caused during the day, repairing and regenerating skin cells at a faster rate," advised leading New York City based dermatologist and author of Skin Rules Dr. Debra Jaliman, M.D.  "In a clinical study, subjects who used Mederma® PM for 8 weeks as directed saw noticeable improvement in the size of scars in as little as 2-4 weeks and a 50% reduction in the size of the scars after 8 weeks."

Available in the First Aid and Skin Care sections of  drugstores nationwide, Mederma® PM fits easily into existing beauty regimens, given it is applied once-nightly and can be used with moisturizers and anti-aging creams,but patients should consult their healthcare professionals before using Mederma® PM with topical prescription products. Mederma® PM may be used on scars on the face and the body resulting from injury, cuts, surgery, burns and acne. For best results, Mederma® PM should be applied evenly and gently rubbed into the scar once nightly for eight weeks on new scars and once nightly for three to six months on existing scars.

"Data shows that nearly half of women try to hide their skin imperfections, such as scars, and admit that their self-confidence would improve if they could reduce the appearance of these skin imperfections," said Emily Klopp, Sr. Brand Manager. "We are thrilled to offer a new product that addresses the growing interest in nighttime skin care, while also effectively reducing the appearance of these skin imperfections, helping women to feel more confident in their own skin!"

To help ensure effective and appropriate product use, Mederma® offers text, email and calendar reminders. Additionally, a one-of-a-kind iPhone app, the Mederma® Progress Tracker, allows users to take photos of their scars every few days and create a time-lapse movie to see how Mederma® helped improve the appearance of their scars over time. The app is available in the iTunes App store.

Mederma® PM is sold in a 1-ounce tube and 1.7-ounce jar with suggested retail prices of $25 and $35, respectively.

About Mederma®

The Mederma® family of products, including Mederma® PM,  Mederma® Advanced Scar Gel, Mederma® Scar Cream plus SPF 30, Mederma® for Kids^™ and Mederma® Stretch Marks Therapy, has a long  tradition of visible improvement in the appearance of scars and stretch marks when used as directed. The #1 doctor-¹ and pharmacist-²recommended brand for scars, Mederma® helps reduce the appearance of scars resulting from surgery, injury, burns, and acne, making them softer, smoother, and less noticeable. To learn more, visit www.mederma.com, and follow us on Facebook at www.facebook.com/Mederma.

About Merz

Merz North America is a specialty healthcare company that develops and commercializes innovative treatment solutions in aesthetics, dermatology and neurosciences in the U.S. and Canada.  Our ambition is to become a recognized leader in the treatment of movement disorders, and in aesthetics and dermatology. Our future is promising, and we are committed to advancing new therapeutic options and improving patients' lives.

For more than 100 years, the development of our products has been based on Merz's commitment to providing innovative medical approaches that earn trust of patients, physicians and partners worldwide. Globally, the companies of Merz Pharma Group are focused on medications for treating neurological and psychiatric illnesses, and they have assumed a leading role in the field of Alzheimer's disease research.  Founded in 1908, Merz Pharma Group is a privately owned company headquartered in Frankfurt, Germany.

REFERENCES
¹ IMS Health NDTI, December 2013.
² Pharmacy Times and U.S. News & World Report, OTC Guide, June 2013.

Photo - http://photos.prnewswire.com/prnh/20140331/NY91550-a

Logo - http://photos.prnewswire.com/prnh/20140331/NY91550LOGO-b

SOURCE Merz